These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20649758)

  • 41. Silent myocardial ischemia detected by single photon emission computed tomography (SPECT) and risk of cardiac events among asymptomatic patients with type 2 diabetes: a meta-analysis of prospective studies.
    Zhang L; Li H; Zhang S; Jaacks LM; Li Y; Ji L
    J Diabetes Complications; 2014; 28(3):413-8. PubMed ID: 24529748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TLR-4+ peripheral blood monocytes and cardiovascular events in patients with chronic kidney disease--a prospective follow-up study.
    Lorenzen JM; David S; Richter A; de Groot K; Kielstein JT; Haller H; Thum T; Fliser D
    Nephrol Dial Transplant; 2011 Apr; 26(4):1421-4. PubMed ID: 21239386
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Surveillance study for creating the national clinical database related to ECG-gated myocardial perfusion SPECT of ischemic heart disease: J-ACCESS study design.
    Kusuoka H; Nishimura S; Yamashina A; Nakajima K; Nishimura T
    Ann Nucl Med; 2006 Apr; 20(3):195-202. PubMed ID: 16715950
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of renal function on mortality and incidence of major adverse cardiovascular events following acute coronary syndromes.
    Lourenço C; Teixeira R; António N; Monteiro S; Baptista R; Jorge E; Gonçalves F; Monteiro P; Gonçalves L; Freitas M; Providência LA
    Rev Port Cardiol; 2010 Sep; 29(9):1331-52. PubMed ID: 21179976
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic syndrome is not a predictor for cardiovascular events in Japanese patients with diabetes mellitus asymptomatic for coronary artery disease: a retrospective analysis of the J-ACCESS-2 study.
    Nakajima K; Takeishi Y; Matsuo S; Yamasaki Y; Nishimura T
    J Nucl Cardiol; 2013 Apr; 20(2):234-41. PubMed ID: 23196975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiac event risk in Japanese subjects estimated using gated myocardial perfusion imaging, in conjunction with diabetes mellitus and chronic kidney disease.
    Nakajima K; Matsuo S; Okuyama C; Hatta T; Tsukamoto K; Nishimura S; Yamashina A; Kusuoka H; Nishimura T
    Circ J; 2012; 76(1):168-75. PubMed ID: 22104035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myocardial perfusion imaging for predicting cardiac events in Japanese patients with advanced chronic kidney disease: 1-year interim report of the J-ACCESS 3 investigation.
    Joki N; Hase H; Kawano Y; Nakamura S; Nakajima K; Hatta T; Nishimura S; Moroi M; Nakagawa S; Kasai T; Kusuoka H; Takeishi Y; Momose M; Takehana K; Nanasato M; Yoda S; Nishina H; Matsumoto N; Nishimura T
    Eur J Nucl Med Mol Imaging; 2014 Sep; 41(9):1701-9. PubMed ID: 24827603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiovascular events in Japanese asymptomatic patients with type 2 diabetes: a 1-year interim report of a J-ACCESS 2 investigation using myocardial perfusion imaging.
    Nakajima K; Yamasaki Y; Kusuoka H; Izumi T; Kashiwagi A; Kawamori R; Shimamoto K; Yamada N; Nishimura T
    Eur J Nucl Med Mol Imaging; 2009 Dec; 36(12):2049-57. PubMed ID: 19593560
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Re: nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses: C. J. Weight, B. T. Larson, A. F. Fergany, T. Gao, B. R. Lane, S. C. Campbell, J. H. Kaouk, E. A. Klein and A. C. Novick J Urol 2010; 183: 1317-1323.
    Patel N; Sullivan M; Cranston D
    J Urol; 2010 Nov; 184(5):2213-4; author reply 2214. PubMed ID: 20864134
    [No Abstract]   [Full Text] [Related]  

  • 50. Myocardial perfusion is a useful screening test for the evaluation of cardiovascular risk in patients undergoing simultaneous pancreas kidney transplantation.
    Ruparelia N; Bhindi R; Sabharwal N; Mason P; Klucniks A; Sinha S; Friend P; Ormerod OJ
    Transplant Proc; 2011 Jun; 43(5):1797-800. PubMed ID: 21693281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic risk stratification of myocardial ischaemia evaluated by gated myocardial perfusion SPECT in patients with chronic kidney disease.
    Hatta T; Nishimura S; Nishimura T
    Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1835-41. PubMed ID: 19471925
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of myocardial perfusion imaging for cardiovascular events among asymptomatic Japanese patients with type 2 diabetes and mild renal dysfunction.
    Okuyama C; Nakajima K; Yamasaki Y; Nishimura T
    Nucl Med Commun; 2013 Apr; 34(4):328-32. PubMed ID: 23376861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Further evidence for the robustness of regadenoson stress myocardial perfusion SPECT: its predictive value for cardiac events in chronic renal failure.
    Caobelli F; Bengel FM
    Eur Heart J Cardiovasc Imaging; 2014 Aug; 15(8):941-2. PubMed ID: 24714138
    [No Abstract]   [Full Text] [Related]  

  • 54. Chronic kidney disease as a potent risk modifier for CAD in diabetics.
    Fink JC
    JACC Cardiovasc Imaging; 2010 Jul; 3(7):746-8. PubMed ID: 20633853
    [No Abstract]   [Full Text] [Related]  

  • 55. Value of thallium myocardial imaging in the prediction of future cardiovascular events in patients with end-stage renal failure.
    Brown JH; Vites NP; Testa HJ; Prescott MC; Hunt LP; Gokal R; Mallick NP
    Nephrol Dial Transplant; 1993; 8(5):433-7. PubMed ID: 8393548
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Usefulness of risk grading system using albuminuria for predicting cardiovascular events and all-cause death in chronic kidney disease: a population-based prospective cohort study in Japan.
    Koeda Y; Tanaka F; Segawa T; Ohta M; Ohsawa M; Tanno K; Makita S; Ishibashi Y; Omama S; Onoda T; Nakamura M
    Int J Cardiol; 2014 Aug; 175(3):576-7. PubMed ID: 24874904
    [No Abstract]   [Full Text] [Related]  

  • 57. External validation and update of the J-ACCESS model in an Italian cohort of patients undergoing stress myocardial perfusion imaging.
    Petretta M; Megna R; Assante R; Zampella E; Nappi C; Gaudieri V; Mannarino T; Green R; Cantoni V; D'Antonio A; Panico M; Acampa W; Cuocolo A
    J Nucl Cardiol; 2023 Aug; 30(4):1443-1453. PubMed ID: 36598749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rationale and design of the MASTERPLAN study: Multifactorial approach and superior treatment efficacy in renal patients with the aid of nurse practitioners.
    Van Zuilen AD; Wetzels JF; Blankestijn PJ; Bots ML; Van Buren M; Ten Dam MA; Kaasjager KA; Van De Ven PJ; Vleming LJ; Ligtenberg G; Ligtenberg G;
    J Nephrol; 2005; 18(1):30-4. PubMed ID: 15772920
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular risk assessment with regadenoson SPECT MPI in patients with end-stage renal disease is safe, effective, and well tolerated: Does it matter?
    Miller EO; Schwartz RG
    J Nucl Cardiol; 2017 Feb; 24(1):119-121. PubMed ID: 26626782
    [No Abstract]   [Full Text] [Related]  

  • 60. Cardiovascular imaging in patients with chronic kidney disease.
    Karohl C; Raggi P
    Blood Purif; 2011; 31(1-3):130-7. PubMed ID: 21228581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.